Expression of IL-23 and IL-17 and effect of IL-23 on IL-17 production in ankylosing spondylitis
- 27 February 2009
- journal article
- research article
- Published by Springer Science and Business Media LLC in Rheumatology International
- Vol. 29 (11), 1343-1347
- https://doi.org/10.1007/s00296-009-0883-x
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- The IL-23/IL-17 axis in inflammationJCI Insight, 2006
- Anti-IL-23 therapy inhibits multiple inflammatory pathways and ameliorates autoimmune encephalomyelitisJCI Insight, 2006
- Understanding the IL-23–IL-17 immune pathwayTrends in Immunology, 2006
- Interleukin-17 Family Members and InflammationImmunity, 2004
- Treatment with a neutralizing anti‐murine interleukin‐17 antibody after the onset of collagen‐induced arthritis reduces joint inflammation, cartilage destruction, and bone erosionArthritis & Rheumatism, 2004
- Divergent Pro- and Antiinflammatory Roles for IL-23 and IL-12 in Joint Autoimmune InflammationThe Journal of Experimental Medicine, 2003
- Interleukin-23 Promotes a Distinct CD4 T Cell Activation State Characterized by the Production of Interleukin-17Journal of Biological Chemistry, 2003
- IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesisJCI Insight, 1999
- Interleukin-17 and Interferon-γ Synergize in the Enhancement of Proinflammatory Cytokine Production by Human KeratinocytesJournal of Investigative Dermatology, 1998
- Evaluation of Diagnostic Criteria for Ankylosing SpondylitisArthritis & Rheumatism, 1984